Out-of-specification (OOS) results were found in reference samples for the atomoxetine content parameter, which may affect the quality and effectiveness of the medicine. Potential effects: lack or reduced treatment efficacy, possible worsening of disease symptom control.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Atofab from batches E01580 and FQ6874, check the batch number on the pack; if you have these batches, consult a pharmacist or doctor to obtain an appropriate replacement or further advice.
Suspension throughout the country of the marketing of batches E01580 and FQ6874 of the medicinal product Atofab (Atomoxetine), hard capsules, 25 mg and 40 mg, and granting the decision immediate enfor...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related